secwatch.observer — SEC 8-K summary
======================================

Issuer:     Telesis Bio Inc. (—)
CIK:        0001850079
Form:       8-K
Filed at:   2024-04-08T23:59:59+00:00
Accession:  0000950170-24-042617
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Telesis Bio receives Nasdaq delisting notice for insufficient stockholders' equity
--------------------------------------------------------------------------------

- Received Nasdaq notice for non-compliance with minimum $10M stockholders' equity requirement on April 3, 2024.
- Must submit compliance plan by May 20, 2024; may get extension until Sep 30, 2024 if plan accepted.
- Common stock continues trading under TBIO on Nasdaq Global Select for now.
- 2024 Annual Meeting set for May 1, 2024; shareholder proposals due April 18, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850079/000095017024042617/0000950170-24-042617-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850079/000095017024042617/tbio-20240403.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-042617

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer